Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNA

Journal of Viral Hepatitis

Volumn 21, Issue 9, 2014, Pages

  Kohno, T ^a   Tsuge, M ^a   Murakami, E ^a   Hiraga, N ^a   Abe, H ^a   Miki, D ^a,b   Imamura, M ^a   Ochi, H ^a,b   Hayes, C N ^a   Chayama, K ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

HB core; hepatitis B virus; hsa miR 1231; human hepatocyte chimeric mouse; microRNA

Indexed keywords

CHEMOKINE; CYTOKINE; HEPATITIS B VIRUS X PROTEIN; HSA MICRORNA 1231; HSA MICRORNA 1908; HSA MICRORNA 486 3P; HSA MICRORNA 675; INTERFERON; MICRORNA; MICRORNA 886 5P; UNCLASSIFIED DRUG; UROKINASE; VIRUS MESSENGER RNA; HEPATITIS B CORE ANTIGEN; MIRN1231 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE C; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RNA ANALYSIS; RNA PROCESSING; SCID MOUSE; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; GENETICS; HEPG2 CELL LINE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; HEP G2 CELLS; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MICE, SCID; MICROARRAY ANALYSIS; MICRORNAS; VIRUS REPLICATION;

EID: 84905483932     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12240     Document Type: Article

References (32)

1. Gagneux P, Muchmore EA,. The chimpanzee model: contributions and considerations for studies of hepatitis B virus. Methods Mol Med 2004; 96: 289-318.
2. Ganem D, Schneider RJ,. Hepadnaviridae: The viruses and their replication. In:, Knipe DM, Howely PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, eds. Fields Virology, 4th edn, Vol. 2. Philadelphia, PA: Lippincott Williams & Wilkins, 2001: 2923-69.
3. Raney AK, McLachlan A,. The biology of hepatitis B virus. In:, McLachlan A, ed. Molecular Biology of the Hepatitis B Virus, Boca Raton, FL: CRC Press, Inc., 1991: 1-37.
4. Belloni L, Allweiss L, Guerrieri F, et al,. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 2012; 122 (2): 529-537.
5. Belloni L, Pollicino T, De Nicola F, et al,. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A 2009; 106 (47): 19975-19979.
6. Newbold JE, Xin H, Tencza M, et al,. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 1995; 69 (6): 3350-3357.
7. Pollicino T, Belloni L, Raffa G, et al,. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 2006; 130 (3): 823-837.
8. Tuttleman JS, Pourcel C, Summers J,. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986; 47 (3): 451-460.
9. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M,. Control of cccDNA function in hepatitis B virus infection. J Hepatol 2009; 51 (3): 581-592.
10. Bouchard MJ, Schneider RJ,. The enigmatic X gene of hepatitis B virus. J Virol 2004; 78 (23): 12725-12734.
11. Tsuge M, Takahashi S, Hiraga N, et al,. Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice. J Infect Dis 2011; 204 (2): 224-228.
12. Ambros V, Bartel B, Bartel DP, et al,. A uniform system for microRNA annotation. RNA 2003; 9 (3): 277-279.
13. Bala S, Marcos M, Szabo G,. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009; 15 (45): 5633-5640.
14. Guo H, Liu H, Mitchelson K, et al,. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology 2011; 54 (3): 808-819.
15. Hayes CN, Akamatsu S, Tsuge M, et al,. Hepatitis B virus-specific miRNAs and argonaute2 play a role in the viral Life cycle. PLoS One 2012; 7 (10): e47490.
16. Lan SH, Wu SY, Zuchini R, et al,. Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of miR-224. Hepatology 2013; 59 (2): 505-517.
17. Li C, Wang Y, Wang S, et al,. Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol 2013; 87 (4): 2193-2205.
18. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H,. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res 2010; 88 (2): 169-175.
19. Zhang X, Zhang E, Ma Z, et al,. Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology 2011; 53 (5): 1476-1485.
20. Henke JI, Goergen D, Zheng J, et al,. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008; 27 (24): 3300-3310.
21. Huntzinger E, Izaurralde E,. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011; 12 (2): 99-110.
22. Jopling CL, Schutz S, Sarnow P,. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008; 4 (1): 77-85.
23. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309 (5740): 1577-1581.
24. Machlin ES, Sarnow P, Sagan SM,. Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci U S A 2011; 108 (8): 3193-3198.
25. Tsuge M, Hiraga N, Takaishi H, et al,. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology 2005; 42 (5): 1046-1054.
26. Tateno C, Yoshizane Y, Saito N, et al,. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 2004; 165 (3): 901-912.
27. Dweep H, Sticht C, Pandey P, Gretz N,. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011; 44 (5): 839-847.
28. Noguchi C, Ishino H, Tsuge M, et al,. G to A hypermutation of hepatitis B virus. Hepatology 2005; 41 (3): 626-633.
29. Tsuge M, Hiraga N, Akiyama R, et al,. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. J Gen Virol 2010; 91 (Pt 7): 1854-1864.
30. Hiraga N, Imamura M, Tsuge M, et al,. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon. FEBS Lett 2007; 581 (10): 1983-1987.
31. Kimura T, Imamura M, Hiraga N, et al,. Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice. J Gen Virol 2008; 89 (Pt 9): 2108-2113.
32. Walters KA, Joyce MA, Thompson JC, et al,. Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis. Virol J 2006; 3: 37.